BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 16020216)

  • 21. Study of the incidence and nature of "very subtle epidermal melasma" in relation to intense pulsed light treatment.
    Negishi K; Kushikata N; Tezuka Y; Takeuchi K; Miyamoto E; Wakamatsu S
    Dermatol Surg; 2004 Jun; 30(6):881-6; discussion 886. PubMed ID: 15171766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fractional photothermolysis for photoaging of hands.
    Jih MH; Goldberg LH; Kimyai-Asadi A
    Dermatol Surg; 2008 Jan; 34(1):73-8. PubMed ID: 18053047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of efficacy and safety of rucinol serum in patients with melasma: a randomized controlled trial.
    Khemis A; Kaiafa A; Queille-Roussel C; Duteil L; Ortonne JP
    Br J Dermatol; 2007 May; 156(5):997-1004. PubMed ID: 17388924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-dose 1064-nm Q-switched Nd:YAG laser for the treatment of melasma.
    Choi M; Choi JW; Lee SY; Choi SY; Park HJ; Park KC; Youn SW; Huh CH
    J Dermatolog Treat; 2010 Jul; 21(4):224-8. PubMed ID: 20509814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of histological findings of single session Er:YAG skin fractional resurfacing with various passes and energies and the possible clinical implications.
    Trelles MA; Vélez M; Mordon S
    Lasers Surg Med; 2008 Mar; 40(3):171-7. PubMed ID: 18366083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fractional Laser treatment for pigmentation and texture improvement.
    Rahman Z; Alam M; Dover JS
    Skin Therapy Lett; 2006 Nov; 11(9):7-11. PubMed ID: 17075654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fractional photothermolysis: a novel aesthetic laser surgery modality.
    Hantash BM; Mahmood MB
    Dermatol Surg; 2007 May; 33(5):525-34. PubMed ID: 17451574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Photorejuvenation by intense pulsed light with objective measurement of skin color in Japanese patients.
    Negishi K; Kushikata N; Takeuchi K; Tezuka Y; Wakamatsu S
    Dermatol Surg; 2006 Nov; 32(11):1380-7. PubMed ID: 17083592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topical 10% zinc sulfate solution for treatment of melasma.
    Sharquie KE; Al-Mashhadani SA; Salman HA
    Dermatol Surg; 2008 Oct; 34(10):1346-9. PubMed ID: 18616534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical evaluation of a single-wavelength fractional laser and a novel multi-wavelength fractional laser in the treatment of photodamaged skin.
    Geraghty LN; Biesman B
    Lasers Surg Med; 2009 Aug; 41(6):408-16. PubMed ID: 19588529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of a novel fractional resurfacing device for treatment of acne scarring.
    Walgrave SE; Ortiz AE; MacFalls HT; Elkeeb L; Truitt AK; Tournas JA; Zelickson BD; Zachary CB
    Lasers Surg Med; 2009 Feb; 41(2):122-7. PubMed ID: 19226575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy in melasma treatment using a 1410 nm fractional photothermolysis laser.
    Wanitphakdeedecha R; Keoprasom N; Eimpunth S; Manuskiatti W
    J Eur Acad Dermatol Venereol; 2014 Mar; 28(3):293-7. PubMed ID: 23347253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of melasma using a novel 1,927-nm fractional thulium fiber laser: a pilot study.
    Polder KD; Bruce S
    Dermatol Surg; 2012 Feb; 38(2):199-206. PubMed ID: 22093448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of a Low Energy, Low Density, Non-Ablative Fractional 1927 nm Wavelength Laser for Facial Skin Resurfacing.
    Brauer JA; Alabdulrazzaq H; Bae YS; Geronemus RG
    J Drugs Dermatol; 2015 Nov; 14(11):1262-7. PubMed ID: 26580875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-ablative 1,550 nm fractional laser therapy versus triple topical therapy for the treatment of melasma: a randomized controlled split-face study.
    Wind BS; Kroon MW; Meesters AA; Beek JF; van der Veen JP; Nieuweboer-Krobotová L; Bos JD; Wolkerstorfer A
    Lasers Surg Med; 2010 Sep; 42(7):607-12. PubMed ID: 20806385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intense pulsed light treatment of persistent facial hypermelanosis following drug-induced toxic epidermal necrolysis.
    Paquet P; Piérard GE
    Dermatol Surg; 2004 Dec; 30(12 Pt 2):1522-5. PubMed ID: 15606831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The treatment of melasma with fractional photothermolysis: a pilot study.
    Rokhsar CK; Fitzpatrick RE
    Dermatol Surg; 2005 Dec; 31(12):1645-50. PubMed ID: 16336881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Erbium:YAG laser resurfacing for refractory melasma.
    Manaloto RM; Alster T
    Dermatol Surg; 1999 Feb; 25(2):121-3. PubMed ID: 10037517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical trial of pin-point photodynamic therapy using an optic fiber for the improvement of enlarged facial pores: a case study.
    Kim S; Cho KH
    J Dermatolog Treat; 2009; 20(1):36-41. PubMed ID: 19003590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic outcome of melasma treatment by dual-wavelength (511 and 578 nm) laser in patients with skin phototypes III-V.
    Eimpunth S; Wanitphakdeedecha R; Triwongwaranat D; Varothai S; Manuskiatti W
    Clin Exp Dermatol; 2014 Apr; 39(3):292-7. PubMed ID: 24635063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.